Biotech Startups

CellTrack develops a cell-labeling technology that attaches Zirconium-89 to therapeutic cells for non-invasive PET imaging, allowing tracking of cell biodistribution in vivo for over 7 days. The company targets pharma companies and CDMOs developing cell therapies, aiming to provide biodistribution data for clinical trials.

1 investor

Cellular Agriculture Ltd develops hollow fibre bioreactor technology for sustainable, scalable cell culture across cultivated food, biopharmaceuticals, cosmetics, and animal health applications. The company designs modular, cell- and media-agnostic bioreactor systems engineered for industrial-scale production.

1 investor

Cellular Highways manufactures the Highway1 Cell Sorter, a benchtop instrument for high-throughput cell sorting applications in research. The company serves life science researchers requiring fast, gentle cell sorting with high cell viability.

1 investor

Cellumed is a South Korean biotech company focused on musculoskeletal medical devices and biological products. It also develops and supplies growth factors and production enzymes used for RNA vaccines and therapeutics.

1 investor

Cellva creates natural ingredients from Brazilian agricultural supply chains using proprietary technology to transform raw materials into food-grade solutions. The company serves food manufacturers and CPG brands seeking to improve formulation efficiency, cost reduction, and sensory performance in food applications.

1 investor

Cellworks develops AI-driven mechanistic biology models that simulate how an individual patient will respond to drug therapies by combining molecular modeling, clinical guidelines, and over 300 million patient records. It serves biopharma drug development teams and physicians with applications across precision oncology, population health, and care delivery.

1 investor

Celmatix Therapeutics developed a discovery portfolio focused on women's health, including therapeutic programs for infertility, endometriosis, and ovarian aging. The company's pipeline included an oral FSH receptor agonist, a JNK inhibitor, and AMH-targeting antibodies.

1 investor

Cementic is a dental biotechnology company. Its website is under construction and provides no detailed information about its products or services.

1 investor

Cenevo is a life science technology company that provides integrated lab management software combining electronic lab notebooks, LIMS, sample management, and AI-enabled automation for research organizations. The platform serves biotech firms, pharmaceutical companies, and research institutions seeking to streamline lab operations and accelerate scientific discovery.

1 investor

Centaur Pharmaceuticals is an integrated Indian pharmaceutical company operating across active pharmaceutical ingredients (APIs), finished formulations, clinical research, and contract manufacturing, with distribution reaching 120 countries. It manufactures psychotropic APIs and branded formulations such as the anti-cold brand Sinarest, and conducts clinical trials through its LifeSan research arm.

1 investor

Cephagenix is a biotech company working on identifying and developing new treatments for migraine.

1 investor

Cerapedics develops P-15 peptide enhanced bone graft products, marketed as bone growth accelerators, for spinal fusion procedures. Its US FDA-approved products PearlMatrix (lumbar/TLIF) and i-FACTOR (cervical/ACDF) are used by surgeons for spine surgery.

1 investor

Next-generation targeted radiotherapeutics for cancer patients.

1 investor

Pharmaceutical company developing novel approach to Alzheimer's disease

1 investor

Cerevanta provides AI-powered analysis of brain imaging to help neurologists make clinical decisions more effectively. The platform targets neurology care providers to reduce diagnostic delays and improve patient outcomes.

1 investor

CereVasc is developing the eShunt System, a minimally invasive device intended to treat communicating hydrocephalus in children and adults as an alternative to invasive neurosurgical procedures. The company operates in the medical device sector for neurological conditions.

1 investor

Cergentis is now part of Solvias and provides Targeted Locus Amplification (TLA) technology and genetic characterization services for advanced therapy development. The company serves pharmaceutical and biotech innovators with CMC analytical testing from drug development through commercialization.

1 investor

1 investor

CERTANIA provides testing, inspection, and certification services across areas such as food testing, pharmaceutical examination, and building inspection. It combines technical expertise with digital tools to deliver these safety and compliance services to customers.

1 investor

Certara provides biosimulation software, modeling, and regulatory services that support drug discovery and development across discovery, preclinical, clinical, regulatory, and market access phases. It serves pharmaceutical and biotech organizations seeking to make data-driven decisions and streamline regulatory submissions.

1 investor

Certified Laboratories operates a network of 30+ ISO 17025-accredited testing labs across North America, providing microbiology, analytical chemistry, contract research, and certification & audit services. It serves the food & beverage industry as well as cosmetics, personal care, over-the-counter drug, dietary supplement, and botanical companies with safety and quality testing.

1 investor

Cerulea Clinical Trials runs ophthalmic clinical trials focused on vision research, giving patients access to new therapies and clinical care. It also offers CeruleaCONNECT, a program that keeps healthcare practitioners informed about recruiting and upcoming eye-related trials so they can refer eligible patients.

1 investor

Ceryx Medical develops medical device technology, presenting a leadership and research team alongside its publications. The page provides limited detail on the specific product beyond the company's medical technology focus.

1 investor

Cumberland Emerging Technologies provides development partnerships with researchers and companies to advance early-stage biomedical technologies toward commercialization, and operates a life sciences incubator facility in Nashville offering laboratory space and support services to pharmaceutical, medical device, and diagnostics firms.

1 investor